Literature DB >> 20075706

Clinical and serologic correlations and autoantibody clusters in systemic lupus erythematosus: a retrospective review of 917 patients in South China.

Xuhua Tang1, Yanmei Huang, Wenmin Deng, Lipeng Tang, Weizhen Weng, Xingqi Zhang.   

Abstract

Ethnicity and environmental factors could be involved in the heterogeneity of systemic lupus erythematosus (SLE). We conducted this study to define clinical and serologic correlations and autoantibody clusters in SLE patients in South China. We retrospectively reviewed the records of 917 patients with SLE admitted to our hospital between January 2005 and June 2008. We found the following associations between autoantibodies and clinical manifestations to be statistically significant: anti-double-stranded DNA (anti-dsDNA) with higher prevalence of renal disorder, leukopenia, and anemia; anti-Sm with higher prevalence of malar rash/discoid rash, pericarditis, and leukopenia; anti-ribonucleoprotein (anti-RNP) with higher prevalence of Raynaud phenomenon and photosensitivity; anti-deoxyribonucleoprotein (anti-DNP) with higher prevalence of arthritis and lower prevalence of renal disorder; anti-Scl-70 with higher prevalence of anemia and Raynaud phenomenon; anti-Jo-1 with higher prevalence of pericarditis; and anti-centromere with higher prevalence of Raynaud phenomenon. Three autoantibody clusters were identified: Cluster 1 (anti-Ro, anti-Sm, and anti-RNP [Ro/Sm/RNP], with a significantly lower percentage of elderly SLE and higher prevalence of photosensitivity, malar rash/discoid rash, Raynaud phenomenon, and leukopenia); Cluster 2 (anti-Ro [Ro], with a lower percentage of pediatric SLE); and Cluster 3 (the absence of anti-extractable nuclear antigen antibodies [ENA ve], with a lower percentage of adult SLE and lower prevalence of alopecia). In summary, this study not only confirms both anti-dsDNA and anti-Sm as specific markers for classifying SLE, but also demonstrates that photosensitivity is not associated with anti-Ro but with anti-RNP, and a negative association is found between renal disorder and anti-DNP in patients in South China. These results are different from results found in other populations. The higher prevalence of anti-dsDNA and renal disorder results in less difference in the prevalence of anti-dsDNA and renal disorder among the 3 autoantibody clusters in SLE patients in South China, which could be related to ethnicity and widespread industrial pollution in South China.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20075706     DOI: 10.1097/MD.0b013e3181cb449c

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  16 in total

1.  Prognosis of patients with systemic lupus erythematosus and discoid lesions.

Authors:  Thelma Larocca Skare; Bárbara Stadler; Emilio Weingraber; Diogo F De Paula
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

2.  Predictors of predominant Lupus Low Disease Activity State (LLDAS-50).

Authors:  H Babaoglu; J Li; D Goldman; L S Magder; M Petri
Journal:  Lupus       Date:  2019-11-06       Impact factor: 2.911

3.  Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort.

Authors:  Mariangelí Arroyo-Ávila; Yesenia Santiago-Casas; Gerald McGwin; Ryan S Cantor; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Robert P Kimberly; Graciela S Alarcón; Luis M Vilá; Elizabeth E Brown
Journal:  Clin Rheumatol       Date:  2015-04-22       Impact factor: 2.980

4.  Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort.

Authors:  Yesenia Santiago-Casas; Luis M Vilá; Gerald McGwin; Ryan S Cantor; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Robert P Kimberly; Graciela S Alarcón; Elizabeth E Brown
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

5.  Two major autoantibody clusters in systemic lupus erythematosus.

Authors:  Kathryn H Ching; Peter D Burbelo; Christopher Tipton; Chungwen Wei; Michelle Petri; Ignacio Sanz; Michael J Iadarola
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

6.  Performance of Anti-Topoisomerase I Antibody Testing by Multiple-Bead, Enzyme-Linked Immunosorbent Assay and Immunodiffusion in a University Setting.

Authors:  Kate LaRiviere Homer; Jeffrey Warren; Dmitry Karayev; Puja P Khanna; Amber Young; Vivek Nagaraja; Allan L Metzger; Dinesh Khanna
Journal:  J Clin Rheumatol       Date:  2020-04       Impact factor: 3.902

7.  Chinese SLE treatment and research group registry: III. association of autoantibodies with clinical manifestations in Chinese patients with systemic lupus erythematosus.

Authors:  Jing Li; Xiaomei Leng; Zhijun Li; Zhizhong Ye; Caifeng Li; Xiaofeng Li; Ping Zhu; Zhengang Wang; Yi Zheng; Xiangpei Li; Miaojia Zhang; Xin-Ping Tian; Mengtao Li; Jiuliang Zhao; Feng-Chun Zhang; Yan Zhao; Xiaofeng Zeng
Journal:  J Immunol Res       Date:  2014-04-23       Impact factor: 4.818

8.  Multiple Autoantibodies Display Association with Lymphopenia, Proteinuria, and Cellular Casts in a Large, Ethnically Diverse SLE Patient Cohort.

Authors:  Rufei Lu; Julie M Robertson; Benjamin F Bruner; Joel M Guthridge; Barbara R Neas; Swapan K Nath; Jennifer A Kelly; Kathy L Moser Sivils; Eliza F Chakravarty; Diane L Kamen; Gary S Gilkeson; Daniel J Wallace; Michael H Weisman; R Hal Scofield; John B Harley; Judith A James
Journal:  Autoimmune Dis       Date:  2012-09-04

9.  Evaluation of the patient acceptable symptom state (PASS) in Italian patients affected by systemic lupus erythematosus: association with disease activity indices.

Authors:  Fabrizio Conti; Fulvia Ceccarelli; Laura Massaro; Viviana A Pacucci; Francesca Miranda; Simona Truglia; Enrica Cipriano; Francesco Martinelli; Ilaria Leccese; Francesca Romana Spinelli; Cristiano Alessandri; Carlo Perricone; Guido Valesini
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

10.  Associates and predictors of pleurisy or pericarditis in SLE.

Authors:  Seungwon Ryu; Wei Fu; Michelle A Petri
Journal:  Lupus Sci Med       Date:  2017-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.